Systematic evolution of ligands by exponential enrichment: Solution SELEX
AssigneeUniversity Research Corporation
InventorsLarry Gold, Steven Ringquist
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity Research Corporation
InventorsLarry Gold, Steven Ringquist
Estimating the term…
Described herein are methods for improved partitioning between high and low affinity nucleic acid ligands identified through the SELEX method, termed solution SELEX. The solution SELEX method achieves partitioning between high and low affinity nucleic acid-target complexes through a number of methods, including (1) primer extension inhibition which results in differentiable cDNA products. Primer extension inhibition is achieved with the use of nucleic acid polymerases, including DNA or RNA polymerases, reverse transcriptase, and Q.beta.-replicase; (2) exonuclease hydrolysis inhibition which results in only the highest affinity ligands amplifying during PCR. This is achieved with the use of any 3'.fwdarw.5' double-stranded exonuclease; (3) linear to circle formation to generate molecules amplifiable during PCR; or (4) PCR amplification of single-stranded nucleic acids. A central theme of the method of the present invention is that the nucleic acid candidate mixture is screened in solution and results in preferential amplification of the highest affinity RNA ligand or catalytic RNA.
A method for identifying nucleic acid ligands from a candidate mixture of nucleic acids, said nucleic acid ligands being a ligand of a given target molecule comprising:
A method for identifying nucleic acid ligands from a candidate mixture of nucleic acids, said nucleic acid ligands being a ligand of a given target molecule comprising:
A method for identifying double-stranded nucleic acid ligands from a candidate mixture of nucleic acids, said double-stranded nucleic acid ligands being a ligand of a given target molecule comprising:
Dependencies are inferred from the claim text.